Shares of Pacific Biosciences of California Inc. (NASDAQ:PACB) traded at a new 52-week high today of $51.88. So far today approximately 712,000 shares have been exchanged, as compared to an average 30-day volume of 5.2 million shares.
In the past 52 weeks, Pacific Biosciences of California Inc. share prices are bracketed by a low of $2.20 and a high of $51.88 and is now at $46.94, 2,034% above that low price.
Pacific Biosciences of California Inc. has overhead space with shares priced $46.94, or 37.7% below the average consensus analyst price target of $75.41.
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company’s revenue is derived from North America, followed by Asia and Europe.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer